Associate Professor, Neurological Sciences, Rush Medical College of Rush Univ
Neurology
Dr. Dusan Stefoski, MD
|
|
Give Review
Dr. Dusan Stefoski works in the field of Neurology. He has 1 awards "CMS Meaningful Use Stage 1 Certification". Doctor Dusan Stefoski, MD is a published MD as well. He has 36 publications published. The latest was: Treatment of autoimmune disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation. He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Is cervical decompression beneficial in patients with coexistent cervical stenosis and Multiple sclerosis?
- Autoimmune Aquaporin-4 Myopathy in Neuromyelitis Optica Spectrum.
- Cross-immunoreactivity between bacterial aquaporin-Z and human aquaporin-4: potential relevance to neuromyelitis Optica.
- Meningiomas with conspicuous plasma cell-lymphocytic components: a report of five cases.
- Nonhomogeneous distribution of 5-hydroxyindoleacetic acid and homovanillic acid in the lumbar cerebroSpinal fluid of man.
- Correlation between diffuse EEG abnormalities and Cerebral atrophy in senile dementia.
- 4-Aminopyridine in Multiple sclerosis: prolonged administration.
- Orally administered 4-aminopyridine improves clinical signs in Multiple sclerosis.
- Selective blockade of components of potassium activation in Myxicola axons.
- 4-Aminopyridine improves clinical signs in Multiple sclerosis.
- Is steroid therapy in Multiple sclerosis superior to corticotropin therapy?
- Acute improvement in exacerbating Multiple sclerosis produced by intravenous administration of mannitol.
- Toward a treatment logic for sleep apnea: the place of the tongue retaining device.
- Evaluation of cervical stimulation for chronic treatment of spasticity.
- Development of somatizing responses in Multiple sclerosis.
- Partial plasma protein replacement in therapeutic plasma exchange.
- Plasmapheresis decreases neuroelectric blocking activity in Multiple sclerosis.
- Mechanism of action of 4-aminopyridine in the symptomatic treatment of Multiple sclerosis.
- Validation of the functional assessment of Multiple sclerosis quality of life instrument.
- Myogenic and central neurogenic factors in fatigue in Multiple sclerosis.
- T cell-depleted autologous hematopoietic stem cell transplantation for Multiple sclerosis: report on the first three patients.
- Treatment of autoimmune Disease by intense immunosuppressive conditioning and autologous hematopoietic stem cell transplantation.
- Fluoroscopically guided percutaneous needle biopsy of the cervical Spinal cord.
- Hematopoietic stem cell transplantation for progressive Multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progressi...
- Hematopoietic stem cell transplantation for Multiple sclerosis.
- Development of a secondary autoimmune disorder after hematopoietic stem cell transplantation for autoimmune Diseases: role of conditioning regimen used.
- Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting Multiple sclerosis: a phase I/II study.
- Effect of natalizumab on clinical and radiological disease activity in Multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing...
- A pilot test of pioglitazone as an add-on in patients with relapsing remitting Multiple sclerosis.
- Methylation patterns of cell-free plasma DNA in relapsing-remitting Multiple sclerosis.
- Central nervous system expression of interferon regulatory factor 1 regulates experimental autoimmune encephalomyelitis.
- Freedom from disease activity in Multiple sclerosis.
- IRF-1 signaling in central nervous system glial cells regulates Inflammatory demyelination.
- Overexpression of the dominant-negative form of interferon regulatory factor 1 in oligodendrocytes protects against experimental autoimmune encephalomyelitis.
- Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS.
Schools
University Of Zagreb
Rush Presby St Luke39s M C
Procedures Preformed
- Baclofen Pump Therapy
- EEG (Electroencephalogram)
- Steroid Injection
Conditions Treated
- Ataxia
- Brain Aneurysm
- Brain Injury
- Cerebral Hemorrhage
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Rush University Medical Center -
Stanford University -
University of Zagreb Faculty of Medicine
Hospital
-
Rush University Medical Center
Drug Facts
| NPI NUMBER | 1376521724 | |
| NPPES Provider LastName | STEFOSKI | |
| NPPES Provider FirstName | DUSAN | |
| NPPES Provider ZIPCode | 606123824 | |
| NPPES Provider State | IL | |
| Specialty Description | Neurology | |
| Total Claim Count | 1579.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1376521724 |
| Last Name Of The Provider | STEFOSKI |
| First Name Of The Provider | DUSAN |
| View All |
Similar Doctors
|
|
Dr. Peter T. Heydemann, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. E Richard R. Blonsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Senda Ajroud-Driss, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua D. Baron, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephan U. Schuele, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Leonard D. Elkun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathryn E. Ess, MD |
|
|
Dr. Jennifer P. Rubin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric M. Liotta, MD |
|
|
Dr. Ali Mansour, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ilana M. Ruff, MD
This Doctor is OpenDoctor Recommended.
|